Enhancing Adherence and Knowledge of Erlotinib in Patients Wtih Non-Small Cell Lung Cancer: A Feasibility Pilot Study
Phase of Trial: Phase IV
Latest Information Update: 25 Jun 2012
At a glance
- Drugs Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 25 Jun 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
- 25 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jun 2011 New trial record